Gt Biopharma Stock Forecast

Sell candidate since Jul 09, 2026 Loss -4.96%

The GT Biopharma, Inc. stock price fell by -4.96% on the last day (Friday, 10th Jul 2026) from $0.447 to $0.425. During the last trading day the stock fluctuated 8.05% from a day low at $0.413 to a day high of $0.446. The price has risen in 6 of the last 10 days and is up by 2.14% over the past 2 weeks. Volume has increased on the last day by 200 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $442.46 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.81% during the next 3 months and, with a 90% probability hold a price between $0.527 and $0.743 at the end of this 3-month period.

GTBP Signals & Forecast

There are few to no technical positive signals at the moment. The GT Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $0.465 and $0.450. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 18, 2026, and so far it has fallen -17.32%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). GT Biopharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for GT Biopharma, Inc. stock

GT Biopharma, Inc. finds support from accumulated volume at $0.419 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0332 between high and low, or 8.05%. For the last week, the stock has had daily average volatility of 8.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GTBP) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect GT Biopharma, Inc. to open at $0.428, and during the day (based on 14 day Average True Range), to move between $0.402 and $0.448, which gives a possible trading interval of +/-$0.0451 (+/-11.21%) up or down from last closing price. If GT Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 11.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.430 (1.18%) than the support at $0.419 (1.34%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is GT Biopharma, Inc. stock A Buy?

The GT Biopharma, Inc. stock holds several negative signals and despite the positive trend, we believe GT Biopharma, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.892 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.428 ( 0.659%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk